Imperva Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Imperva regular Real Value cannot be determined due to lack of data. The prevalent price of Imperva is 0.0. Our model calculates the value of Imperva from evaluating the firm fundamentals such as Return On Asset of 0.0474, return on equity of 0.0812, and Current Valuation of 1.65 B as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage buying undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Imperva Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Imperva's current stock value. Our valuation model uses many indicators to compare Imperva value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Imperva competition to find correlations between indicators driving Imperva's intrinsic value. More Info.Imperva is rated third overall in price to earning category among related companies. It is currently regarded as number one stock in price to book category among related companies fabricating about 0.08 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Imperva is roughly 12.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Imperva by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Imperva's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imperva's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Imperva's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Imperva and how it compares across the competition.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Imperva Stock
If you are still planning to invest in Imperva check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Imperva's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges |